P
Pernilla Lagergren
Researcher at Karolinska University Hospital
Publications - 170
Citations - 5374
Pernilla Lagergren is an academic researcher from Karolinska University Hospital. The author has contributed to research in topics: Population & Cancer. The author has an hindex of 36, co-authored 141 publications receiving 4232 citations. Previous affiliations of Pernilla Lagergren include King's College London & Karolinska Institutet.
Papers
More filters
Journal ArticleDOI
Recent developments in esophageal adenocarcinoma
TL;DR: Esophageal adenocarcinoma (EAC) is characterized by 6 striking features: increasing incidence, male predominance, lack of preventive measures, opportunities for early detection, demanding surgical therapy and care, and poor prognosis as mentioned in this paper.
Journal ArticleDOI
Health‐related quality of life among patients cured by surgery for esophageal cancer
Pernilla Lagergren,Pernilla Lagergren,Kerry N L Avery,Rachael A. Hughes,C Paul Barham,Derek Alderson,Stephen Falk,Jane M Blazeby +7 more
TL;DR: Little is known regarding the long‐term, health‐related quality of life (HRQL) of survivors of esophagectomy for cancer.
Journal ArticleDOI
Cachexia in patients with oesophageal cancer
TL;DR: Screening for cachexia by means of percentage weight loss and BMI during the cancer trajectory and survivorship periods is imperative, and markers of inflammation, dysphagia and appetite loss should be assessed at diagnosis.
Journal ArticleDOI
Influence of Major Postoperative Complications on Health-Related Quality of Life Among Long-Term Survivors of Esophageal Cancer Surgery
TL;DR: The occurrence of postoperative complications exerts a long-lasting negative effect on HRQL in patients who survive 5 years after esophageal cancer surgery, with clinically and statistically significantly deteriorated throughout the follow-up.
Journal ArticleDOI
Long-term health-related quality of life following surgery for oesophageal cancer.
TL;DR: The aim of the study was to assess health‐related quality of life (HRQL) in patients with surgically cured oesophageal cancer.